HKD 7.71
(0.13%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 18.52 Million CNY | 845.27% |
2022 | 2.52 Million CNY | -97.62% |
2021 | 106.19 Million CNY | -4.01% |
2020 | 110.62 Million CNY | 71.97% |
2019 | 64.32 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 15.62 Million CNY | 0.0% |
2024 Q1 | 15.62 Million CNY | 274.17% |
2023 FY | 23.88 Million CNY | 845.27% |
2023 Q1 | 17.4 Million CNY | 161.14% |
2023 Q4 | -8.97 Million CNY | -110.29% |
2023 Q3 | -4.26 Million HKD | -124.51% |
2023 Q2 | 17.4 Million CNY | 0.0% |
2022 Q2 | 16.27 Million CNY | 0.0% |
2022 Q1 | 16.27 Million CNY | -50.1% |
2022 FY | 2.52 Million CNY | -97.62% |
2022 Q4 | -28.47 Million CNY | 0.0% |
2022 Q3 | -28.47 Million CNY | -274.99% |
2021 Q1 | 21.74 Million CNY | 0.0% |
2021 FY | 106.19 Million CNY | -4.01% |
2021 Q4 | 32.6 Million CNY | 0.0% |
2021 Q3 | 32.6 Million CNY | 49.97% |
2021 Q2 | 21.74 Million CNY | 0.0% |
2020 FY | 110.62 Million CNY | 71.97% |
2019 FY | 64.32 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Life Healthcare Group Limited | 17.63 Million HKD | -5.058% |
China Biotech Services Holdings Limited | -127.67 Million HKD | 114.51% |